Norwegian Gynecological Cancer Registry
The Norwegian Gynecological Cancer Registry includes ovarian cancer (cancer of the ovary, fallopian tubes and peritoneum) and cervical cancer.
499 women got ovarian cancer and 322 women got cervical cancer in Norway in 2023.
The purpose of the registry is to contribute to strengthen the quality of the health care provided to patients with gynaecological cancer. The registry is also conduct, promote and provide a basis for research to develop new knowledge about the causes, diagnosis, course of disease and treatment effects of cancer. The Cancer Registry of Norway is responsible for data processing for the registry.
National Quality Registry for Gynecological Cancer on kvalitetsregistre.no
Facts about ovarian and cervical cancer on kreftregisteret.no
Information on the Norwegian Cancer Society's pages about ovarian and uterine cancer.
Reporting to the registry
Registration of clinical information to the Norwegian Gynecological Cancer Registry is done electronically via KREMT on the Norwegian Health Network. KREMT includes functionalities for making the reporting easier. Reminders for missing messages and receipts for submitted messages are available in the KREMT portal. It is also possible to cache forms.
To encourage reporting, administrative and clinical statistics have been compiled that provide hospitals with updated results for their unit. These statistics are updated daily.
Degree of coverage and data quality
Patient group
The registry contains detailed information on all cases of cancer of the ovary, fallopian tubes and peritoneum as well as cervix (ICD 10: C56, C57, C48, C53), and information from assessment, treatment and follow-up of the patient group.
Gynecological cancers are treated with various combinations of surgery, hormone therapy, chemotherapy and radiation therapy.
Levels of care
Patients with gynaecological cancer are assessed, treated and followed up by both the primary health service and the specialist health service. All doctors who provide health care to patients with gynaecological cancer are obliged to report to the Cancer Registry, which includes the Norwegian Gynecological Cancer Registry.
Findings (Norwegian only)